Taken together, our data, for the first time, indicate that treatment with Lip-MSA-IL-2 + TAB004 significantly improved survival in an orthotopic model, and resulted in retardation of tumor progression in a spontaneous model of PDA. Here, IL2 is linked to neoplasm.